Advances in the management of pulmonary disease due to Mycobacterium abscessus complex
Publication in refereed journal

替代計量分析
.

其它資訊
摘要Mycobacterium abscessus complex is a group of rapidly growing mycobacteria, and an emerging cause of non-tuberculous mycobacterial lung disease in patients with cystic fibrosis and chronic lung diseases, such as bronchiectasis. M. abscessus complex is the most drug-resistant of the mycobacterial pathogens, resulting in limited therapeutic options and a high treatment failure rate. M. abscessus complex is comprised of three closely related subspecies: M. abscessus (sensu stricto), M. massiliense and M. bolletii. M. abscessus encodes a functional erythromycin ribosomal methylase gene, erm(41), which modifies the binding site for macrolide antibiotics, causing inducible macrolide resistance. However, this inducible macrolide resistance is not seen in M. massiliense, as the erm(41) gene of this subspecies is non-functional. Accordingly, treatment success rates with macrolide-based antibiotic treatment are much higher in patients with M. massiliense infections than in those infected with M. abscessus. Precise speciation of M. abscessus complex is important for predicting antibiotic susceptibilities and patient outcome.
著者Koh WJ, Stout JE, Yew WW.
期刊名稱International Journal of Tuberculosis and Lung Disease
出版年份2014
月份10
卷號18
期次10
出版社International Union Against Tuberculosis and Lung Disease
頁次1141 - 1148
國際標準期刊號1027-3719
語言英式英語

上次更新時間 2020-15-10 於 02:42